On Wednesday 10 April in Brussels, the European Parliament endorsed its position to reform EU pharmaceutical legislation in order to encourage innovation and strengthen the security of supply and accessibility of medicines.
The ‘pharmaceutical legislative package’, which substantially amends the European Commission’s proposals on medicinal products for human use, was adopted by a very large majority: the report by Pernille Weiss (EPP, Danish) amending the proposed directive was...